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Sir
Generalized granuloma annulare (GGA) is an uncommon 
variant of granuloma annulare (GA) presenting with 
multiple asymptomatic or slightly pruritic, skin‑colored, 
or erythematous papules, which may coalesce into annular 
plaques, occurring on trunk and extremities. Typically, GGA 
shows a protracted course and poor response to therapy.[1,2] 
Hepatitis C virus (HCV) infection may be associated with 
such disease.[3] We describe the first case of GGA in a HCV 
antibody‑positive cirrhotic patient successfully treated 
with narrowband ultraviolet B (Nb‑UVB) therapy.
A 70‑year‑old woman with a 8‑year history of Child‑Pugh 
class A HCV‑related cirrhosis (previously treated 
unsuccessfully with two cycles of interferon plus 
ribavirin, the last of which two years earlier) presented 
with numerous mildly pruritic, partially confluent, 
pink‑reddish papules on the trunk and limbs of 4 months 
duration [Figures 1a and b]. The patient denied drug 
intake or other significant health problems. Routine 
laboratory examinations showed no alteration except for 
hypoalbuminemia (2.8 mg/dl) and a slightly prolonged 
prothrombin time (INR value of 1.7) due to chronic liver 
failure. Antinuclear antibodies and HIV serology were 
negative. Histopathology from a papule showed interstitial 
infiltration of histiocytes and lymphocytes in upper and 
medium dermis [Figure 2a] Colloidal iron stain displayed 
mucin deposition in reticular dermis [Figure 2b]. 
Therefore, a diagnosis of GGA was made. The patient was 
treated with Nb‑UVB therapy (three times weekly) with 
a starting dose of 0.35 J/cm2 and subsequent increments 
of 10% every session. After 8 weeks the lesions regressed 
[Figures 3a and b], and there was no recurrence after 
3 months of follow‑up. No side‑effects were observed.
Although many anecdotal therapies have been used with 
varying degrees of success in the treatment of GGA,[1] 
the literature supports the use of isotretinoin, dapsone 
and phototherapy with oral psoralen and ultraviolet 
A (PUVA) as first‑line options.[2] However, these therapies 
may be associated with significant side‑effects and 
are notoriously contraindicated in patients with liver 
impairment, as in our case.
Bath‑PUVA with sun exposure (PUVASOL)[2] and Nb‑UVB 
therapy[3‑5] are reported to be efficacious in GGA and 
could be considered as ultraviolet‑based alternatives to 
PUVA therapy for patients with hepatic failure since they 
don’t require oral psoralen administration and present 
a good safety profile.[2‑5] Regarding Nb‑UVB therapy, 
Figure 2: Interstitial infiltration of histiocytes and lymphocytes in the upper and 
medium dermis (H and E ×100) (a); mucin deposition in reticular dermis (Colloidal 
iron stain ×50) (b)
ba
Figure 1: Numerous partially confluent, pink‑reddish papules localized on the 
abdomen (inset shows a particular of the lesions) (a) and thighs (b)
ba
Figure 3: Regression of the lesions on the abdomen (a) and thighs (b) after 8 weeks 
of treatment with Nb‑UVB therapy (three weekly) with a starting dose of 0.35 J/cm2 




Inui et al. reported a case of GGA (previously resistant 
to topical steroids and tacrolimus) resulting in resolution 
after 24 sessions,[3] while Yashar et al. described 
another instance with “minimal to mild” response 
(treatment regimen, duration, patient compliance and 
satisfaction were not indicated).[4] Moreover, Nb‑UVB has 
also been successfully used as adjuvant therapy with 
insulin and oral tranilast in a case of eruptive GGA.[3]
Albeit the mechanism by which NB‑UVB acts upon GA 
is not completely clear, it is thought that it is able to 
reduce the lymphoproliferation and cytokine production, 
thus counteracting granuloma formation.[4]
In conclusion, our case confirms the efficacy of Nb‑UVB 
therapy in GGA and emphasizes its utility in patients 
with chronic liver failure, in which first‑line treatments 
are contraindicated. Anyhow, further studies are needed 
to confirm these assumptions.
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